Share on Pinterest A new analysis found that the diabetes medication orforglipron (Foundayo), an oral GLP-1, helped women lose weight regardless of their menopausal status. Healthline/Photo by Eli ...

Weight gain during menopause is common. Learn how weight loss medications such as semaglutide, tirzepatide, and orforglipron might help.

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research. The study, set to be presented at ENDO 2026 (the Endocrine Society’s annual meeting) in ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

The number of people using GLP-1 drugs exclusively for weight loss has surpassed those using them to manage diabetes, according to a new survey from Numerator – though the data analytics firm is not ...

Doctors don’t recommend combining GLP-1 medications with weight loss pills because the safety and effectiveness of these combinations haven’t been established in clinical trials. Combining GLP-1 ...

Women who lost weight after starting GLP-1 medications were more likely to form new partnerships or enter employment, revealing how body weight may influence opportunities at the moment first ...

Before you switch from Wegovy to Zepbound or Ozempic, learn why weight loss plateaus happen and how long you should really ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

GLP-1 receptor agonists are associated with substantial weight loss in adults with overweight or obesity and without diabetes, according to a systematic review. The range of therapeutic options, which ...

Blockbuster GLP-1 receptor agonists revolutionized obesity management in recent years, driving weight loss of up to 20%. This weight loss, however, can carry a notable downside: Studies estimate that ...